Literature DB >> 18763285

Hepatocytes isolated from neoplastic liver-immunomagnetic purging as a new source for transplantation.

Aravin Gunasegaram1, Javed Akhter, Peng Yao, Loreena A Johnson, Stephen M Riodan, David L Morris.   

Abstract

AIM: To investigate whether hepatocytes isolated from macroscopically normal liver during hepatic resection for neoplasia could provide a novel source of healthy hepatocytes, including the development of reliable protocols for malignant cells removal from the hepatocyte preparation.
METHODS: Hepatocytes were procured from resected liver of 18 patients with liver tumors using optimised digestion and cell-enrichment protocols. Suspensions of various known quantities of the HT-29 tumor cell line and patient hepatocytes were treated or not with Ep-CAM-antibody-coated immunomagnetic beads in order to investigate the efficacy of tumor-purging by immunomagnetic depletion, using a semi-quantitative RT-PCR method developed to detect tumor cells. Immunomagnetic bead-treated or bead-untreated tumor cell-hepatocyte suspensions were transplanted intra-peritoneally in Balb/C nude mice to assess the rates of tumor development.
RESULTS: Mean viable hepatocyte yield was 9.3 multiply 10(6) cells per gram of digested liver with mean viability of 70.5%. Immunomagnetic depletion removed tumor cells to below the RT-PCR detection-threshold of 1 tumor cell in 10(6) hepatocytes, representing a maximum tumor purging efficacy of greater than 400000-fold. Transplanted, immunomagnetic bead-purged tumor cell-hepatocyte suspensions did not form peritoneal tumors in Balb/C nude mice. Co-transplantation of hepatocytes with tumor cells did not increase tumorigenesis of the tumor cells.
CONCLUSION: Immunomagnetic depletion appears to be an effective method of purging contaminating tumor cells to below threshold for likely tumorigenesis. Along with improved techniques for isolation of large numbers of viable hepatocytes, normal liver resected for neoplasia has potential as another clinically useful source of hepatocytes for transplantation.

Entities:  

Mesh:

Year:  2008        PMID: 18763285      PMCID: PMC2742930          DOI: 10.3748/wjg.14.5025

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  32 in total

1.  Negative immunomagnetic purging of peripheral blood stem cell harvests from breast carcinoma patients reduces tumor cell contamination while not affecting hematopoietic recovery.

Authors:  P Pedrazzoli; A Lanza; M Battaglia; G A Da Prada; A Zambelli; C Perotti; L Ponchio; L Salvaneschi; G Robustelli della Cuna
Journal:  Cancer       Date:  2000-06-15       Impact factor: 6.860

2.  Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver.

Authors:  C J de Boer; J H van Krieken; C M Janssen-van Rhijn; S V Litvinov
Journal:  J Pathol       Date:  1999-06       Impact factor: 7.996

3.  Hepatocellular transplantation for treatment of D-galactosamine-induced acute liver failure in rats.

Authors:  B G Sommer; D E Sutherland; A J Matas; R L Simmons; J S Najarian
Journal:  Transplant Proc       Date:  1979-03       Impact factor: 1.066

4.  Safety and efficacy of living donor liver preservation with HTK solution.

Authors:  B Ringe; F Braun; M Moritz; G Zeldin; H Soriano; W Meyers
Journal:  Transplant Proc       Date:  2005 Jan-Feb       Impact factor: 1.066

5.  The effects of cryopreservation on human hepatocytes obtained from different sources of liver tissue.

Authors:  Claire Terry; Ragai R Mitry; Sharon C Lehec; Paolo Muiesan; Mohamed Rela; Nigel D Heaton; Robin D Hughes; Anil Dhawan
Journal:  Cell Transplant       Date:  2005       Impact factor: 4.064

Review 6.  The biology of the 17-1A antigen (Ep-CAM).

Authors:  M Balzar; M J Winter; C J de Boer; S V Litvinov
Journal:  J Mol Med (Berl)       Date:  1999-10       Impact factor: 4.599

7.  Human hepatocyte isolation and relationship of cell viability to early graft function.

Authors:  Ragai R Mitry; Robin D Hughes; Marion M Aw; Claire Terry; Giorgina Mieli-Vergani; Raffaele Girlanda; Paolo Muiesan; Mohamed Rela; Nigel D Heaton; Anil Dhawan
Journal:  Cell Transplant       Date:  2003       Impact factor: 4.064

8.  Tissue collection, transport and isolation procedures required to optimize human hepatocyte isolation from waste liver surgical resections. A multilaboratory study.

Authors:  Lysiane Richert; Eliane Alexandre; Tom Lloyd; Samantha Orr; Catherine Viollon-Abadie; Rakhee Patel; Shaun Kingston; David Berry; Ashley Dennison; Bruno Heyd; Georges Mantion; Daniel Jaeck
Journal:  Liver Int       Date:  2004-08       Impact factor: 5.828

9.  Isolation and culture of primary human hepatocytes.

Authors:  Edward L LeCluyse; Eliane Alexandre; Geraldine A Hamilton; Catherine Viollon-Abadie; D James Coon; Summer Jolley; Lysiane Richert
Journal:  Methods Mol Biol       Date:  2005

10.  Significant improvement of survival by intrasplenic hepatocyte transplantation in totally hepatectomized rats.

Authors:  B A Vogels; M A Maas; A Bosma; R A Chamuleau
Journal:  Cell Transplant       Date:  1996 May-Jun       Impact factor: 4.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.